Scivision Biotech Inc. (1786)
Market Closed
15 Oct, 05:30 AM
TWSE TWSE Primary NT$
40. 25
-0.55
-1.348%
NT$
5.91B Market Cap
15.55 P/E Ratio
- Div Yield
253,480 Volume
5.99 Eps
NT$ 40.8
Previous Close Want to track 1786 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Scivision Biotech Inc. (1786) Statistics
Valuation metrics
Market Cap 5.91B
Enterprise value 2.93B
Trailing P/E (ttm) 17.16
Forward P/E -
PEG ratio 3.3
Price/Sales (ttm) 3.51
Price/Book (mrq) 1.73
Enterprise Value/Revenue 3.29
Enterprise Value/EBITDA 11.18
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 164.86K
Average volume (90 days) 173.18K
Price summary
52-Week low 40.25
52-Week high 96.8
Beta -
50-Day moving average 44.83
200-Day moving average 53.09
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.91
Trailing annual dividend yield 0.0458%
5-Year annual dividend yield -
Payout ratio 0.8
Dividend Date 29 May 2026
Ex-Dividend Date 29 Apr 2026
Last split factor 1,085:1,000
Last split Date 4 Oct 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.2%
Operating margin 0.16%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 11.98
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.4
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.2
Total debt (mrq) -
Total Debt/Equity (mrq) 0.27
Current ratio (mrq) 6.46%
Book value per share (mrq) 24.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
